Alaunos Therapeutics Inc (TCRT) — Capital Reinvestment Ratio
Latest as of September 2015:
0.00x
Alaunos Therapeutics Inc (TCRT) has a Capital Reinvestment Ratio of 0.00x as of September 2015, meaning it reinvests 0% of its operating cash flow ($45.20 Million) in capital expenditures ($3.00K). See how leveraged is Alaunos Therapeutics Inc's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$45.20 Million
USD
Capital Expenditures
$3.00K
USD
Data as of
Sep 2015
Most recent filing
Annual Capital Reinvestment Ratio for Alaunos Therapeutics Inc (None–None)
Year-by-year Capital Reinvestment Ratio for Alaunos Therapeutics Inc from None to None. For live market cap and broader valuation context, see how much is Alaunos Therapeutics Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow